Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines.
Junichi Sakamoto, Kenneth O. Lloyd(Institute for Protein Innovation), Koichi Furukawa(Chubu University), Carlos Cordon‐Cardo(Icahn School of Medicine at Mount Sinai), Lloyd J. Old(Gynecologic Oncology Group), Wolfgang J. Rettig(Boehringer Ingelheim (Austria)), Beatrice W.T. Yin(Memorial Sloan Kettering Cancer Center), Herbert F. Oettgen
PubMed
March 1, 1986
Cited by 233
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
|Cancer Research|2008|1.1k
Tumor-infiltrating NY-ESO-1–specific CD8 <sup>+</sup> T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
|Proceedings of the National Academy of Sciences|2010|844